iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

The registry intends to provide real world data on patient management and quality of care for patients with T2DM, hypertension, heat failure and chronic kidney disease in clinical practice in many countries. To bridge this gap an observational voluntary registry is set up to capture real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart Failure and Chronic Kidney Disease. Multinational, observational registry utilizing a cloud-based eCRF, for prospective and retrospective data collection, accessible to investigators and Scientific Committee. This registry will be open to all physicians managing T2DM, HTN, HF or CKD across the world

• 1. Incidence of Level 1 Hypoglycemic Events (Blood Glucose <70 mg/dL) [Time frame: Average of 3 years]
• 2.Incidence of Level 2 Hypoglycemic Events (Blood Glucose <54 mg/dL) [Time frame: Average of 3 years]
• 3.Incidence of Level 3 Hypoglycemic Events (Requiring Third-Party Assistance) [Time frame: Average of 3 years]
• 4.Incidence of Diabetic Ketoacidosis (DKA) Episodes [Time frame: Average of 3 years]
• 5. Percentage of Participants with Uncontrolled Type 2 Diabetes (HbA1c ≥7%) [Time frame: Average of 3 years]
• 6. Percentage of Participants with Uncontrolled Hypertension (BP ≥140/90 mmHg) [Time frame: Average of 3 years]
• 7. Incidence of Retinopathy [Time frame: Average of 3 years]
• 8. Incidence of Nephropathy [Time frame: Average of 3 years]
• 9. Incidence of Neuropathy [Time frame: Average of 3 years]
• 10. Incidence of Myocardial Infarction (MI) [Time frame: Average of 3 years]
• 11. Incidence of Stroke [Time frame: Average of 3 years]
• 12. Incidence of Peripheral Arterial Disease (PAD) [Time frame: Average of 3 years]